The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Open accessAbstract
Cancer cells hijack and remodel existing metabolic pathways for their benefit. Argininosuccinate synthase (ASS1) is a urea cycle enzyme that is essential in the conversion of nitrogen from ammonia and aspartate to urea. A decrease in nitrogen flux through ASS1 in the liver causes the urea cycle disorder citrullinaemia. In contrast to the well-studied consequences of loss of ASS1 activity on ureagenesis, the purpose of its somatic silencing in multiple cancers is largely unknown. Here we show that decreased activity of ASS1 in cancers supports proliferation by facilitating pyrimidine synthesis via CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, and dihydroorotase complex) activation. Our studies were initiated by delineating the consequences of loss of ASS1 activity in humans with two types of citrullinaemia. We find that in citrullinaemia type I (CTLN I), which is caused by deficiency of ASS1, there is increased pyrimidine synthesis and proliferation compared with citrullinaemia type II (CTLN II), in which there is decreased substrate availability for ASS1 caused by deficiency of the aspartate transporter citrin. Building on these results, we demonstrate that ASS1 deficiency in cancer increases cytosolic aspartate levels, which increases CAD activation by upregulating its substrate availability and by increasing its phosphorylation by S6K1 through the mammalian target of rapamycin (mTOR) pathway. Decreasing CAD activity by blocking citrin, the mTOR signalling, or pyrimidine synthesis decreases proliferation and thus may serve as a therapeutic strategy in multiple cancers where ASS1 is downregulated. Our results demonstrate that ASS1 downregulation is a novel mechanism supporting cancerous proliferation, and they provide a metabolic link between the urea cycle enzymes and pyrimidine synthesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic or epigenetic silencing of ASS1 expression provides an advantage to tumor cells by allowing them to preserve cellular aspartate (Rabinovich et al., 2015), a poorly transported nutrient that can be a critical output of the TCA cycle to support de novo nucleotide synthesis and cell proliferation (Birsoy et al., 2015; Sullivan et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Rabinovich et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use
Varma, A., & Palsson, B. Ø. (1994) · Nature Biotechnology · doi:10.1038/nbt1094-994 · Cited by 945
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby‐Arnon, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 480
Self-citationArginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Single-molecule transcript counting of stem-cell markers in the mouse intestine
Itzkovitz, S., Lyubimova, A., Blat, I. C., Maynard, M. A., van Es, J. H., Lees, J. A., Jacks, T., Clevers, H. C., & van Oudenaarden, A. (2011) · Nature Cell Biology · doi:10.1038/ncb2384 · Cited by 352
Self-citationLee, J. K., Havaleshko, D. M., Cho, H., Weinstein, J. N., Kaldjian, E. P., Karpovich, J. F., Grimshaw, A. S., & Theodorescu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610292104 · Cited by 311
Integrative Genome Comparison of Primary and Metastatic Melanomas
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon‐Cardo, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010770 · Cited by 262
Flagged first, then by citations
Research works printed but not linked: 1
- Kobayashi, K., Saheki, T. & Song, Y. Z. Citrin deficiency. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1181/ (2005)
Cited by
Sorted by citations
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,877
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Regulation and metabolic functions of mTORC1 and mTORC2
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855
Sullivan, M. R., Danai, L. V., Lewis, C. A., Chan, S. H., Gui, D. Y., Kunchok, T., Dennstedt, E. A., Vander Heiden, M. G., & Muir, A. (2019) · eLife · doi:10.7554/elife.44235 · Cited by 588
Metabolic reprogramming in clear cell renal cell carcinoma
Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.59 · Cited by 587
Increased demand for NAD(+) relative to ATP drives aerobic glycolysis
Luengo, A., Li, Z., Gui, D. Y., Sullivan, L. B., Zagorulya, M., Do, B. T., Ferreira, R., Naamati, A., Ali, A., Lewis, C. A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.012 · Cited by 547
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics
Shen, X., Wang, R., Xiong, X., Yin, Y., Cai, Y. A., Ma, Z., Liu, N., & Zhu, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-09550-x · Cited by 373
Autophagy maintains tumour growth through circulating arginine
Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0697-7 · Cited by 363
Aspartate is an endogenous metabolic limitation for tumour growth
Sullivan, L. B., Luengo, A., Danai, L. V., Bush, L. N., Diehl, F. F., Hosios, A. M., Lau, A. N., Elmiligy, S., Malstrom, S. E., Lewis, C. A., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0125-0 · Cited by 349
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Kim, J., Hu, Z., Cai, L., Li, K., Choi, E., Faubert, B., Bezwada, D., Rodriguez-Canales, J., Villalobos, P., Lin, Y.-F., et al. (2017) · Nature · doi:10.1038/nature22359 · Cited by 325
Rewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P. W., Carracedo, A., & Erez, A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0054-z · Cited by 330
Self-citationTargeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Fendt, S., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 327
Self-citationSingle-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Quinn, J. J., Jones, M. G., Okimoto, R. A., Nanjo, S., Chan, M. M., Yosef, N., Bivona, T. G., & Weissman, J. S. (2021) · Science · doi:10.1126/science.abc1944 · Cited by 319
Targeting amino acid metabolism for cancer therapy
Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.003 · Cited by 293
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Lee, J. S., Adler, L. N., Karathia, H., Carmel, N. N., Rabinovich, S., Auslander, N., Keshet, R., Stettner, N., Silberman, A., Agemy, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.019 · Cited by 304
Self-citationWatch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism
Lahiri, V., Hawkins, W. D., & Klionsky, D. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.003 · Cited by 287
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E. S., Sahu, U., & Ben‐Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 289
Role of tumor and host autophagy in cancer metabolismPreprint
Poillet-Perez, L., & White, E. (2019) · Genes & Development · doi:10.1101/gad.325514.119 · Cited by 273
Arginine Signaling and Cancer Metabolism
Chen, C., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Cancers · doi:10.3390/cancers13143541 · Cited by 276
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 272
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
Missiroli, S., Perrone, M., Genovese, I., Pinton, P., & Giorgi, C. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102943 · Cited by 263
Nielsen, J. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044757 · Cited by 252
DNA Damage, Repair, and Cancer Metabolism
Turgeon, M., Perry, N. J. S., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00015 · Cited by 249
Serine, glycine and one‑carbon metabolism in cancer (Review)
Pan, S., Fan, M., Liu, Z., Li, X., & Wang, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5158 · Cited by 227
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225
The multifaceted role of autophagy in cancer
Russell, R. C., & Guan, K. (2022) · The EMBO Journal · doi:10.15252/embj.2021110031 · Cited by 244
The Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 214
Szlosarek, P. W., Steele, J. P. C., Nolan, L., Gilligan, D., Taylor, P. D., Spicer, J. F., Lind, M., Mitra, S. S., Shamash, J., Phillips, M. M., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3049 · Cited by 203
p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
Li, L., Mao, Y., Zhao, L., Li, L., Wu, J., Zhao, M., Du, W., Li, Y., & Jiang, P. (2019) · Nature · doi:10.1038/s41586-019-0996-7 · Cited by 203
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Dietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 213
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Wang, W., Cui, J., Ma, H., Lü, W., & Huang, J. Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684961 · Cited by 203
Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine
Nielsen, J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.002 · Cited by 204
Fischer, G. M., Gopal, Y. N. V., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 200
Liu, Y., Feng, W., Dai, Y., Bao, M., Yuan, Z., He, M., Qin, Z., Liao, S., He, J., Huang, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.709210 · Cited by 190
Darnell, A. M., Subramaniam, A. R., & O’Shea, E. K. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.041 · Cited by 195
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 184
di Meo, N. A., Lasorsa, F. M., Rutigliano, M., Loizzo, D., Ferro, M., Stella, A., Bizzoca, C., Vincenti, L., Pandolfo, S. D., Riccardo Autorino, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214360 · Cited by 182
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Chalishazar, M. D., Wait, S. J., Huang, F., Ireland, A. S., Mukhopadhyay, A., Lee, Y., Schuman, S. S., Guthrie, M. R., Berrett, K. C., Vahrenkamp, J. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4140 · Cited by 175
Cellular pyrimidine imbalance triggers mitochondrial DNA–dependent innate immunity
Sprenger, H., MacVicar, T., Bahat, A., Fiedler, K. U., Hermans, S., Ehrentraut, D., Ried, K., Milenkovic, D., Bonekamp, N. A., Larsson, N., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00385-9 · Cited by 170
Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction
Cheng, C.-T., Qi, Y., Wang, Y.-C., Chi, K. K., Chung, Y., Ouyang, C., Chen, Y.-R., Oh, M. E., Sheng, X., Tang, Y., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0178-4 · Cited by 164
Nitrogen Metabolism in Cancer and Immunity
Kurmi, K., & Haigis, M. C. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.005 · Cited by 167
Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M., Brashears, C. B., Radyk, M. D., Redlich, N. J., Tzeng, S., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 169
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Mishra, R., Haldar, S., Placencio, V. R., Madhav, A., Rohena-Rivera, K., Agarwal, P., Duong, F. L., Angara, B., Tripathi, M., Liu, Z., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99397 · Cited by 167
Metabolic reprogramming, sensing, and cancer therapy
Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 180
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
Keshet, R., & Erez, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033332 · Cited by 166
Self-citationGCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment
Missiaen, R., Anderson, N. M., Kim, L. C., Nance, B., Burrows, M., Skuli, N., Carens, M., Riscal, R., Steensels, A., Li, F., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.010 · Cited by 154
Clinical development of metabolic inhibitors for oncology
Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R., & Slusher, B. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148550 · Cited by 142
Regulation of nucleotide metabolism in cancers and immune disorders
Ali, E. S., & Ben‐Sahra, I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.003 · Cited by 137
Ochocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 128
The Janus-like role of proline metabolism in cancer
Burke, L. E. C.-A., Guterman, I., Palacios-Gallego, R., Britton, R. G., Burschowsky, D., Tufarelli, C., & Rufini, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00341-8 · Cited by 131
Lercher, A., Bhattacharya, A., Popa, A., Caldera, M., Schlapansky, M. F., Baazim, H., Agerer, B., Gürtl, B., Kosack, L., Májek, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.014 · Cited by 124
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells
Zhang, H., Liu, J., Yuan, W., Zhang, Q., Luo, X. L., Li, Y., Peng, Y., Feng, J., Liu, X., Chen, J., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01503-x · Cited by 127
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 128
Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 121
Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 124
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
Pranzini, E., Pardella, E., Paoli, P., Fendt, S., & Taddei, M. L. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.02.004 · Cited by 116
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Ariav, Y., Ch’ng, J., Christofk, H. R., Ron‐Harel, N., & Erez, A. (2021) · Science Advances · doi:10.1126/sciadv.abg6165 · Cited by 109
Self-citationMetabolomics and Metabolic Reprogramming in Kidney Cancer
Weiss, R. H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.006 · Cited by 110
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Huang, Y., Du, S., Liu, J., Huang, W., Liu, W., Zhang, M., Li, N., Wang, R., Wu, J., Chen, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122245119 · Cited by 109
Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?
Jiang, J., Srivastava, S., & Zhang, J. (2019) · Cancers · doi:10.3390/cancers11060804 · Cited by 108
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
Todisco, S., Convertini, P., Iacobazzi, V., & Infantino, V. (2019) · Cancers · doi:10.3390/cancers12010068 · Cited by 105
Wang, H., Wang, X., Xu, L., Zhang, J., & Cao, H. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09711-4 · Cited by 104
Arginine: at the crossroads of nitrogen metabolism
Fung, T. S., Ryu, K. W., & Thompson, C. B. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00379-3 · Cited by 113
Keshet, R., Lee, J. S., Adler, L. N., Iraqi, M., Ariav, Y., Lim, L. Q. J., Lerner, S., Rabinovich, S., Oren, R., Katzir, R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0106-7 · Cited by 100
Self-citationInterplay between Cellular Metabolism and the DNA Damage Response in Cancer
Moretton, A., & Loizou, J. I. (2020) · Cancers · doi:10.3390/cancers12082051 · Cited by 97
The context-specific roles of urea cycle enzymes in tumorigenesis
Hajaj, E., Sciacovelli, M., Frezza, C., & Erez, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.005 · Cited by 93
Self-citationPyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential
Li, G., Li, D., Wang, T., & He, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910253 · Cited by 102
MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells
Bahat, A., Goldman, A., Zaltsman, Y., Khan, D. H., Halperin, C., Amzallag, E., Krupalnik, V., Mullokandov, M., Silberman, A., Erez, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07519-w · Cited by 90
Self-citationSex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence
Peired, A. J., Campi, R., Angelotti, M. L., Antonelli, G., Conte, C., Lazzeri, E., Becherucci, F., Calistri, L., Serni, S., & Romagnani, P. (2021) · Cancers · doi:10.3390/cancers13184588 · Cited by 92
Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 88
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93
Patel, D., Menon, D., Bernfeld, E., Mroz, V., Kalan, S., Loayza, D., & Foster, D. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710145 · Cited by 86
Zhang, J., Wang, S., Guo, X., Lu, Y., Liu, X., Jiang, M., Li, X., Qin, B., Luo, Z., Liu, H., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05408 · Cited by 89
Guo, L., Yi, X., Chen, L., Zhang, T., Guo, H., Chen, Z., Cheng, J., Cao, Q., Liu, H., Hou, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.052 · Cited by 83
Novel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83
INTEGRATE: Model-based multi-omics data integration to characterize multi-level metabolic regulation
Filippo, M. D., Pescini, D., Galuzzi, B. G., Bonanomi, M., Gaglio, D., Mangano, E., Consolandi, C., Alberghina, L., Vanoni, M., & Damiani, C. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009337 · Cited by 83
Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis
Saab, J. J. A., Dzierozynski, L. N., Jonker, P. B., AminiTabrizi, R., Shah, H., Menjivar, R. E., Scott, A. J., Nwosu, Z. C., Zhu, Z., Chen, R. N., et al. (2023) · eLife · doi:10.7554/elife.81289 · Cited by 84
Progress in the Management of Malignant Pleural Mesothelioma in 2017
McCambridge, A. J., Napolitano, A., Mansfield, A. S., Fennell, D. A., Sekido, Y., Nowak, A. K., Reungwetwattana, T., Mao, W., Pass, H. I., Carbone, M., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.02.021 · Cited by 75
Hajji, N., García‐Revilla, J., Soto, M. S., Perryman, R., Symington, J. J., Quarles, C. C., Healey, D. R., Guo, Y., Orta, M. L., Mateos-Cordero, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci142137 · Cited by 73
Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints
Bezawork‐Geleta, A., Wen, H., Dong, L., Yan, B., Vider, J., Boukalová, Š., Krobova, L., Vanova, K. H., Zobalová, R., Sobol, M. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04603-z · Cited by 73
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 78
Dai, W., Shen, J., Yan, J., Bott, A. J., Maimouni, S., Daguplo, H. Q., Wang, Y., Khayati, K., Guo, J. Y., Zhang, L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161408 · Cited by 70
SLC1A3 contributes to L‐asparaginase resistance in solid tumors
Sun, J., Nagel, R., Zaal, E. A., Ugalde, A. P., Han, R., Proost, N., Song, J., Pataskar, A., Burylo, A. M., Fu, H., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102147 · Cited by 69
Zou, Z., Hu, X., Luo, T., Ming, Z., Chen, X., Li, X., Luo, W., Li, J., Xu, N., Chen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22235-8 · Cited by 70
Chen, M., Zhang, C., Liu, W., Du, X., Liu, X., & Xing, B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.020 · Cited by 70
Hu, Q., Dai, J., Zhang, Z., Yu, H., Zhang, J., Zhu, X., Qin, Y., Zhang, L., & Zhang, P. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1999 · Cited by 71
Santo, C. D., Booth, S., Vardon, A., Cousins, A., Tubb, V., Perry, T., Noyvert, B., Beggs, A. D., Ng, M. H. L., Halsey, C., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31170 · Cited by 72
Hall, P. E., Lewis, R., Syed, N., Shaffer, R. E., Evanson, J., Ellis, S. M., Williams, M., Feng, X., Johnston, A. L., Thomson, J. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3729 · Cited by 70
Metabolic Alterations in Pancreatic Cancer Progression
Vernucci, E., Abrego, J., Gunda, V., Shukla, S. K., Dasgupta, A., Rai, V., Chaika, N. V., Buettner, K. B., Illies, A. L., Yu, F., et al. (2019) · Cancers · doi:10.3390/cancers12010002 · Cited by 69
Li, X., Zhu, H., Sun, W., Yang, X., Nie, Q. H., & Fang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02121-5 · Cited by 69
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
Zhang, J., Zou, S., & Fang, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00977-w · Cited by 73
Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer
Silberman, A., Goldman, O., Assayag, O. B., Jacob, A., Rabinovich, S., Adler, L. N., Lee, J. S., Keshet, R., Sarver, A., Frug, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1062 · Cited by 68
Self-citationArginine depletion as a therapeutic approach for patients with COVID-19
Grimes, J. M., Khan, S. A., Badeaux, M. D., Rao, R. M., Rowlinson, S. W., & Carvajal, R. D. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.100 · Cited by 68
Li, M., Lu, Y., Li, Y., Tong, L., Gu, X., Meng, J., Zhu, Y., Wu, L., Feng, M., Tian, N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3776 · Cited by 68
Metadata
- Authors
- Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., Korman, S., Itzkovitz, S., Dimmock, D., Ulitsky, I., Nagamani, S. C. S., Ruppin, E., & Erez, A.
- Affiliations
- Weizmann Institute of Science (IL)
- Tel Aviv University (IL)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Hadassah Medical Center (IL)
- Corresponding author
- Erez, Ayelet
- ORCID
- Venue
- Nature
- Published
- 2015-11
- Volume
- 527
- Issue
- 7578
- Pages
- 379-383
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4655447
- OpenAlex
- W2129920232
- Cited by
- 382
- References
- 26
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 34 · 2023: 38 · 2022: 48 · 2021: 58 · 2020: 30 · 2019: 32 · 2018: 30 · 2017: 19 · 2016: 15 · 2015: 1
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Doris Duke Charitable Foundation (2013095)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- argininosuccinate synthetase, aspartate transcarbamylase, dihydroorotase, pyrimidine synthesis, urea cycle, citrullinemia, citrin, aspartic acid, mTOR signaling, S6K1, tumor cell proliferation, metabolic reprogramming, citrulline
- MeSH terms
- Animals, Argininosuccinate Synthase, Aspartate Carbamoyltransferase, Aspartic Acid, Calcium-Binding Proteins, Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing), Cytosol, Dihydroorotase, Enzyme Activation, Humans, Male, Neoplasms, Phosphorylation, Pyrimidines, Down-Regulation, Mice, SCID, Citrullinemia, Organic Anion Transporters, Cell Line, Tumor, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
